Chinese Co. Wants $153M Award Vacated In Vitamin C MDL

Law360, Los Angeles (April 11, 2013, 8:40 PM EDT) -- North China Pharmaceutical Group Corp. on Thursday asked a New York federal judge to vacate a recent $153 million award and dismiss multidistrict antitrust litigation alleging illegal collusion in China's vitamin C industry, claiming that only NCPG's indirectly owned subsidiary was involved in the scheme.

The jury confused NCPG with its vitamin C manufacturing unit, HeBei Welcome Pharmaceutical Co. Ltd., last month when it granted a $54.1 million award that a judge later trebled. It was the latter company and its general manager, not NCPG, that...
To view the full article, register now.




Case Information

Case Title

In Re Vitamin C Antitrust Litigation

Case Number



New York Eastern

Nature of Suit



Brian M. Cogan

Date Filed

February 22, 2006

Law Firms

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.